Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine

NCT00003522 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Small Intestine Cancer

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute